Propose a change

Title 35 Public Health and Safety

Write the words of this act the way you think they should read. Solon shows your change as a redline against the published text and pins it to that exact text, so it can never be applied to wording you did not see.

Change 1

What to do with it
As published

35-7-1802. Definitions.

(a) As used in this article: (i) "Eligible patient" means a person who has: (A) A terminal illness; (B) Considered all other treatment options currently approved by the United States food and drug administration; (C) Received a recommendation from a physician for an investigational drug, biological product or device; (D) Given written, informed consent for the use of the investigational drug, biological product or device or, if the patient is a minor or lacks the mental capacity to provide informed consent, a parent or legal guardian has given written informed consent on the patient's behalf; and (E) Documentation from a physician that the person meets the requirements of this paragraph. (ii) "Investigational drug, biological product or device" means a drug, biological product or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States Food and Drug Administration and remains under investigation in a clinical trial; (iii) "Terminal illness" means a disease that, without life-sustaining procedures, will soon result in death or a state of permanent unconsciousness from which recovery is unlikely.

Your change, as a redline

35-7-1802. Definitions.

(a) As used in this article: (i) "Eligible patient" means a person who has: (A) A terminal illness; (B) Considered all other treatment options currently approved by the United States food and drug administration; (C) Received a recommendation from a physician for an investigational drug, biological product or device; (D) Given written, informed consent for the use of the investigational drug, biological product or device or, if the patient is a minor or lacks the mental capacity to provide informed consent, a parent or legal guardian has given written informed consent on the patient's behalf; and (E) Documentation from a physician that the person meets the requirements of this paragraph. (ii) "Investigational drug, biological product or device" means a drug, biological product or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States Food and Drug Administration and remains under investigation in a clinical trial; (iii) "Terminal illness" means a disease that, without life-sustaining procedures, will soon result in death or a state of permanent unconsciousness from which recovery is unlikely.

One line that says what changes, such as "Halve the dog tax".

Who it helps, what it costs, what it fixes. It is what persuades people to support it.

A proposal here is not law. Support on Solon is evidence that people want the change; the official route says what it takes to make it law.

Sign in to file your proposal. What you have written stays on this page.

Sign in to file it